and Davies, M., 2023
Swirl gently until fully dissolved
If you need the most aggressive weight loss intervention available, retatrutide is it
Todays platforms emphasize speed, user control, and discovery
Rather than assuming all patients experience side effects equally, PlexusDx helps bridge the gap between genetic predisposition and clinical practice, enabling discussions about tailored dosing, formulation choice, and escalation speed based on your unique biology
The SUPRPASS-4 trial (262), involving 2002 participants with high-risk cardiovascular profiles followed for up to 104 weeks, showed no difference in 4-MACE events (cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina) with tirzepatide compared to insulin glargine (HR 0.74